CAD 0.13
(0.0%)
Breakdown | 2023 | 2021 | 2020 | 2019 | 2018 | 2017 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | - | 74.73 Thousand | 269.00 | 14.53 Thousand | 51.52 Thousand | - |
Gross Profit | - | -74.73 Thousand | -269.00 | -14.53 Thousand | -51.52 Thousand | - |
Operating Expenses | 2.38 Million | 3.03 Million | 2.49 Million | 3.16 Million | 6.23 Million | 9.14 Million |
Selling, General and Administrative Expenses | 2.38 Million | 2.29 Million | 1.37 Million | 1.99 Million | 3.51 Million | 3.52 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | - | - | - | - |
Cost and Expenses | 2.38 Million | 3.03 Million | 2.49 Million | 3.17 Million | 6.28 Million | 9.14 Million |
Operating Income | -2.38 Million | -3.03 Million | -2.49 Million | -3.21 Million | -6.28 Million | -9.11 Million |
Interest Expense | 61.57 Thousand | 59.18 Thousand | 65.82 Thousand | 42.5 Thousand | 38.2 Thousand | 31.08 Thousand |
Income Tax Expense | 29.47 Thousand | -13.02 Thousand | -99.74 Thousand | -47.7 Thousand | -104.47 Thousand | -224.1 Thousand |
Earnings before Tax | -2.32 Million | -3.15 Million | -2.71 Million | -1.62 Million | -6.55 Million | -9.37 Million |
Net Income | -2.35 Million | -3.13 Million | -2.66 Million | -1.55 Million | -6.41 Million | -9.12 Million |
Earnings Per Share Basic | -0.01 | -0.02 | -0.01 | -0.01 | -0.04 | -0.06 |
Earnings Per Share Diluted | -0.01 | -0.02 | -0.01 | -0.01 | -0.04 | -0.06 |
Weighted Average Shares Outstanding | 204.28 Million | 201.3 Million | 181.22 Million | 177.23 Million | 162.66 Million | 141.83 Million |
Weighted Average Shares Outstanding (Diluted) | 204.28 Million | 201.3 Million | 181.22 Million | 177.23 Million | 162.66 Million | 141.83 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | -2.38 Million | -3 Million | -2.52 Million | -3.05 Million | -6.01 Million | -8.86 Million |
Earnings Before Tax Margin | - | - | - | - | - | - |
Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | - | - | - | - | - | 38.92 Thousand |
Gross Profit | - | - | - | - | - | -38.92 Thousand |
Operating Expenses | 389.89 Thousand | 776.48 Thousand | 985.69 Thousand | 2.38 Million | 380.6 Thousand | 370.87 Thousand |
Selling, General and Administrative Expenses | 315.79 Thousand | 551.6 Thousand | 985.69 Thousand | - | 380.6 Thousand | 258.71 Thousand |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | - | - | - | - |
Cost and Expenses | 389.89 Thousand | 776.48 Thousand | 985.69 Thousand | 2.38 Million | 380.6 Thousand | 370.87 Thousand |
Operating Income | -413.44 Thousand | -803.32 Thousand | -985.7 Thousand | -2.38 Million | -380.61 Thousand | -379.71 Thousand |
Interest Expense | 17.46 Thousand | 16.77 Thousand | 15.08 Thousand | 61.57 Thousand | 16.02 Thousand | 15.54 Thousand |
Income Tax Expense | 5700.00 | -13.27 Thousand | 11.68 Thousand | 29.47 Thousand | 5723.00 | 2403.00 |
Earnings before Tax | -418.67 Thousand | -836.6 Thousand | -1.07 Million | -2.32 Million | -417.32 Thousand | -246.52 Thousand |
Net Income | -424.37 Thousand | -823.32 Thousand | -1.08 Million | -2.35 Million | -423.04 Thousand | -242.22 Thousand |
Earnings Per Share Basic | -0.00 | -0.00 | -0.01 | - | -0.00 | -0.00 |
Earnings Per Share Diluted | -0.00 | -0.00 | -0.01 | - | -0.00 | -0.00 |
Weighted Average Shares Outstanding | 204.28 Million | 204.28 Million | 204.28 Million | 204.28 Million | 204.28 Million | 204.28 Million |
Weighted Average Shares Outstanding (Diluted) | 204.28 Million | 204.28 Million | 204.28 Million | 204.28 Million | 204.28 Million | 204.28 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | -413.44 Thousand | -803.32 Thousand | -985.7 Thousand | - | -380.61 Thousand | -340.78 Thousand |
Earnings Before Tax Margin | - | - | - | - | - | - |
AR
IFBIND
GMMPFAUDLR
RNA
002152
IVT